Romidepsin alone or in combination with anti-CD20 chimeric antigen receptor expanded natural killer cells targeting Burkitt lymphoma in vitro and in immunodeficient mice

Authors: Yaya Chu, Ashlin Yahr, Brian Huang, Janet Ayello, Matthew Barth, Mitchell S. Cairo

Source: OncoImmunology, Vol 6, Iss 9 (2017)

Subject Terms: anti-cd20 chimeric antigen receptor, expanded natural killer cells, rituximab sensitive and resistant burkitt lymphoma, romidepsin, targeted immunotherapy, Immunologic diseases. Allergy, RC581-607, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/2162-402X

Access URL: https://doaj.org/article/3d97c21bef2d4a73ada97bf6a5104891